Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2014 and provided an update on its pipeline and CTP-354.
“We have achieved a number of important milestones so far this year with our diverse pipeline of clinical candidates and look forward to building on these results,” said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
“We have achieved a number of important milestones so far this year with our diverse pipeline of clinical candidates and look forward to building on these results,” said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
